OCUPRESS Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Ocupress, and what generic alternatives are available?

Ocupress is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in OCUPRESS is carteolol hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the carteolol hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ocupress

A generic version of OCUPRESS was approved as carteolol hydrochloride by SANDOZ on January 3^rd, 2000.

Subscribe

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for OCUPRESS?
What are the global sales for OCUPRESS?
What is Average Wholesale Price for OCUPRESS?

Summary for OCUPRESS

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	70
Patent Applications:	822
DailyMed Link:	OCUPRESS at DailyMed

Drug patent expirations by year for OCUPRESS

US Patents and Regulatory Information for OCUPRESS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	OCUPRESS	carteolol hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019972-001	May 23, 1990		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for OCUPRESS

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	OCUPRESS	carteolol hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019972-001	May 23, 1990	⤷ Subscribe	⤷ Subscribe
Novartis	OCUPRESS	carteolol hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019972-001	May 23, 1990	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for OCUPRESS

See the table below for patents covering OCUPRESS around the world.

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Australia	5438673		⤷ Subscribe
Mexico	9203538	COMPOSICIONES PARA TRATAR GLAUCOMA.	⤷ Subscribe
Australia	6338573		⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for OCUPRESS

Make Better Decisions: Try a trial or see plans & pricing